[1]
“CLINICAL AND IMMUNOLOGICAL FEATURES OF THE COURSE OF RHEUMATOID ARTHRITIS AND THE DYNAMICS OF SYSTEMIC INFLAMMATION INDICATORS DURING THE USE OF BASIC, BIOLOGICAL AND TARGETED DRUGS”, ICNSHS, vol. 3, no. 3, pp. 188–189, Jul. 2026, Accessed: Oct. 04, 2026. [Online]. Available: https://universalconference.us/index.php/ICNSHS/article/view/7519